Literature DB >> 23353623

Insulin receptor substrate 1 (IRS1) variants confer risk of diabetes in the Boston Puerto Rican Health Study.

Xiang Feng1, Katherine L Tucker, Laurence D Parnell, Jian Shen, Yu-Chi Lee, José M Ordovás, Wen-Hua Ling, Chao-Qiang Lai.   

Abstract

OBJECTIVE: Published data concerning associations between IRS1 variants and type 2 diabetes and related traits have been inconsistent. We examined the relationship between common variants in IRS1, type 2 diabetes, and related traits including insulin resistance, hyperglycemia and DNA damage in the Boston Puerto Rican Health Study.
METHODS: We genotyped six common IRS1 variants in an adult Puerto Rican population (n=1132) and tested for association with risk of type 2 diabetes and related traits.
RESULTS: SNPs rs934167 and rs1801123 showed significant association with fasting glucose concentrations (p = 0.005 and p = 0.016, respectively) and rs934167 showed significant association with plasma insulin levels (p = 0.005). Carriers of the rs934167 minor allele had significantly higher HOMA-IR and lower QUICKI (p = 0.001 and p = 0.001, respectively), and a 40% and 58% greater likelihood of being hyperglycaemic or hyperinsulinemic (OR = 1.40 and 1.58; p = 0.013 and 0.002, respectively). However, they exhibited only a marginally significant trend towards having type 2 diabetes (OR=1.27, p = 0.077). Furthermore, carriers of the haplotype C-T of the rs934167 and rs1801123 minor alleles showed consistent patterns of associations after correction for multiple testing. In addition, the G972R (rs1801278) minor allele was significantly associated with higher urinary 8-OHdG concentrations (p = 0.020) and plasma CRP levels (p = 0.035).
CONCLUSIONS: Our results support IRS1 variants associated with type 2 diabetes risk in adult Puerto Ricans. Moreover, we report the novel finding that IRS1 variant G972R (rs1801278) may contribute to oxidative DNA damage and inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23353623      PMCID: PMC4428925          DOI: 10.6133/apjcn.2013.22.1.09

Source DB:  PubMed          Journal:  Asia Pac J Clin Nutr        ISSN: 0964-7058            Impact factor:   1.662


  34 in total

1.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

Authors:  A D Pradhan; J E Manson; N Rifai; J E Buring; P M Ridker
Journal:  JAMA       Date:  2001-07-18       Impact factor: 56.272

2.  Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines.

Authors:  R N Kulkarni; J N Winnay; M Daniels; J C Brüning; S N Flier; D Hanahan; C R Kahn
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

3.  The Boston Puerto Rican Health Study, a longitudinal cohort study on health disparities in Puerto Rican adults: challenges and opportunities.

Authors:  Katherine L Tucker; Josiemer Mattei; Sabrina E Noel; Bridgette M Collado; Jackie Mendez; Jason Nelson; John Griffith; Jose M Ordovas; Luis M Falcon
Journal:  BMC Public Health       Date:  2010-03-01       Impact factor: 3.295

Review 4.  Insulin signaling regulating genes: effect on T2DM and cardiovascular risk.

Authors:  Sabrina Prudente; Eleonora Morini; Vincenzo Trischitta
Journal:  Nat Rev Endocrinol       Date:  2009-12       Impact factor: 43.330

5.  Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation.

Authors:  Xiaocheng C Dong; Kyle D Copps; Shaodong Guo; Yedan Li; Ramya Kollipara; Ronald A DePinho; Morris F White
Journal:  Cell Metab       Date:  2008-07       Impact factor: 27.287

6.  Population admixture associated with disease prevalence in the Boston Puerto Rican health study.

Authors:  Chao-Qiang Lai; Katherine L Tucker; Shweta Choudhry; Laurence D Parnell; Josiemer Mattei; Bibiana García-Bailo; Kenny Beckman; Esteban González Burchard; José M Ordovás
Journal:  Hum Genet       Date:  2008-12-24       Impact factor: 4.132

7.  Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia.

Authors:  Johan Rung; Stéphane Cauchi; Anders Albrechtsen; Lishuang Shen; Ghislain Rocheleau; Christine Cavalcanti-Proença; François Bacot; Beverley Balkau; Alexandre Belisle; Knut Borch-Johnsen; Guillaume Charpentier; Christian Dina; Emmanuelle Durand; Paul Elliott; Samy Hadjadj; Marjo-Riitta Järvelin; Jaana Laitinen; Torsten Lauritzen; Michel Marre; Alexander Mazur; David Meyre; Alexandre Montpetit; Charlotta Pisinger; Barry Posner; Pernille Poulsen; Anneli Pouta; Marc Prentki; Rasmus Ribel-Madsen; Aimo Ruokonen; Anelli Sandbaek; David Serre; Jean Tichet; Martine Vaxillaire; Jørgen F P Wojtaszewski; Allan Vaag; Torben Hansen; Constantin Polychronakos; Oluf Pedersen; Philippe Froguel; Robert Sladek
Journal:  Nat Genet       Date:  2009-09-06       Impact factor: 38.330

8.  IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of 'low-frequency-low-risk' variants.

Authors:  E Morini; S Prudente; E Succurro; M Chandalia; Y-Y Zhang; S Mammarella; F Pellegrini; C Powers; V Proto; B Dallapiccola; A Cama; G Sesti; N Abate; A Doria; V Trischitta
Journal:  Diabetologia       Date:  2009-06-26       Impact factor: 10.122

Review 9.  Defects of the insulin receptor substrate (IRS) system in human metabolic disorders.

Authors:  G Sesti; M Federici; M L Hribal; D Lauro; P Sbraccia; R Lauro
Journal:  FASEB J       Date:  2001-10       Impact factor: 5.191

10.  Disparities in allele frequencies and population differentiation for 101 disease-associated single nucleotide polymorphisms between Puerto Ricans and non-Hispanic whites.

Authors:  Josiemer Mattei; Laurence D Parnell; Chao-Qiang Lai; Bibiana Garcia-Bailo; Xian Adiconis; Jian Shen; Donna Arnett; Serkalem Demissie; Katherine L Tucker; Jose M Ordovas
Journal:  BMC Genet       Date:  2009-08-14       Impact factor: 2.797

View more
  7 in total

1.  Circulating 25-hydroxyvitamin D, IRS1 variant rs2943641, and insulin resistance: replication of a gene-nutrient interaction in 4 populations of different ancestries.

Authors:  Ju-Sheng Zheng; Laurence D Parnell; Caren E Smith; Yu-Chi Lee; Aziza Jamal-Allial; Yiyi Ma; Duo Li; Katherine L Tucker; José M Ordovás; Chao-Qiang Lai
Journal:  Clin Chem       Date:  2013-11-19       Impact factor: 8.327

2.  Association between IRS1 Gene Polymorphism and Autism Spectrum Disorder: A Pilot Case-Control Study in Korean Males.

Authors:  Hae Jeong Park; Su Kang Kim; Won Sub Kang; Jin Kyung Park; Young Jong Kim; Min Nam; Jong Woo Kim; Joo-Ho Chung
Journal:  Int J Mol Sci       Date:  2016-07-29       Impact factor: 5.923

3.  Lack of association between the insulin receptor substrates-1 Gly972Arg polymorphism and type-2 diabetes mellitus among Saudis from Eastern Saudi Arabia.

Authors:  Hawra A Alsalman; Yahia A Kaabi
Journal:  Saudi Med J       Date:  2015-12       Impact factor: 1.484

4.  Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus.

Authors:  Dingyu Zhang; Xiaolin Zhang; Dan Liu; Tengfei Liu; Wenzhi Cai; Chenghui Yan; Yaling Han
Journal:  Cardiovasc Diabetol       Date:  2016-03-22       Impact factor: 9.951

Review 5.  Platelets, diabetes and myocardial ischemia/reperfusion injury.

Authors:  Isabella Russo; Claudia Penna; Tiziana Musso; Jasmin Popara; Giuseppe Alloatti; Franco Cavalot; Pasquale Pagliaro
Journal:  Cardiovasc Diabetol       Date:  2017-05-31       Impact factor: 9.951

6.  Three Novel Mutations I65S, R66S, and G86R Divulge Significant Conformational Variations in the PTB Domain of the IRS1 Gene.

Authors:  Praveen Chakravarthi Veeraragavulu; Nanda Kumar Yellapu; Sireesha Yerrathota; Pradeepkiran Jangampalli Adi; Bhaskar Matcha
Journal:  ACS Omega       Date:  2019-01-29

7.  Gene polymorphisms of insulin secretion signaling pathway associated with clopidogrel resistance in Han Chinese population.

Authors:  Jinyan Zhong; Qinglin Yu; Nan Zheng; Jia Su; Xiaowei Zheng; Liangrong Zheng; Xiaomin Chen
Journal:  J Clin Lab Anal       Date:  2021-10-05       Impact factor: 2.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.